Prescription Opioids: Extramedical Use and Overdose

Slides:



Advertisements
Similar presentations
Effectiveness & Cost-Effectiveness of Collaborative Care Depression Treatment in Veterans who screen positive for PTSD Domin Chan, MHS, PhC Northwest HSRD.
Advertisements

Presenters: Cassandra Clement, Pharm.D., BCPS Orlando VA Medical Center Orlando, Florida Chris Stock, Pharm.D., BCPP George E. Wahlen Department of Veterans.
Prescription Opioid Overdose & Misuse in Oregon Mel Kohn, MD MPH Public Health Director and State Public Health Officer Oregon Health Authority Oregon.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2014.
Primary Care-Mental Health Integration in the Department of Veterans Affairs Andrew Pomerantz, MD National Mental Health Director for Integrated Services,
TM Centers for Disease Control and Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention National Center.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2007.
Journal Club Alcohol and Health: Current Evidence July–August 2005.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2011.
Prescription Drug Abuse and Misuse in the Elderly Thomas L. Patterson, Ph.D. Support for this work: NIMH Center Grants P30 MH49693 and MH45131, and by.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
P RESCRIPTION D RUG A BUSE : T HE N ATIONAL P OLICY P ERSPECTIVE Michael Gottlieb, National HIDTA Director Office of National Drug Control Policy May 7,
Opioid Call History Utah Poison Control Center Marty Malheiro, MS, CHES Coordinator, Outreach Education.
Prescription Opioid Use and Opioid-Related Overdose Death — TN, 2009–2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence.
Serving our community by improving health The Addiction Crisis November 2014.
Prescription Drug Abuse Sharon Hertz, M.D. Medical Officer Division of Anesthetic, Critical Care and Addiction Drug Products Food and Drug Administration.
® Introduction Mental Health Predictors of Pain and Function in Patients with Chronic Low Back Pain Olivia D. Lara, K. Ashok Kumar MD FRCS Sandra Burge,
® Introduction Low Back Pain Remedies and Procedures: Helpful or Harmful? Lauren Lyons, Terrell Benold, MD, Sandra Burge, PhD The University of Texas Health.
Chronic Pain Initiative CCNC and Project Lazarus: Chronic Pain and Community Initiative.
Addiction Treatment Works! Through Collaboration and Problem Solving amongst all disciplines.
1 Mental Health and Substance Abuse Services Division Association of Substance Abuse Providers Mike Maples October 5, 2011.
NIDA Grants: U10DA015831, K24DA022288, U10DA020024, K23DA022297, U10DA Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 2/23/20151.
Rx for Success Next Steps to Prevent Prescription Drug Abuse Rebecca Hebner, MPH Substance Abuse Prevention Systems Coordinator.
Opioid Use: What are the technological, clinical, ethical, and regulatory issues? Michael Von Korff Group Health Research Institute.
March 2004 Prescription Drug Abuse in the United States.
Opioid Use in Work-related Injuries Pacific Northwest Chapter - Association of Occupational Health Professionals (AOHP) January 4, 2011 Jaymie Mai, PharmD.
Saves Lives Oklahoma’s Plan to Reduce Prescription Drug Abuse and Prevent Overdose.
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Linking Returning Veterans in Rural Community Colleges to Mental Health Care Justin Hunt, MD, MS Assistant Professor, UAMS Department of Psychiatry South.
Single Convention on Narcotic Drugs Establishes a regulatory system for narcotic drugs government authorization is required for participation in the trade.
The Council of Southeast Pennsylvania, Inc. Overdose Prevention and Education.
Trends in Opioid Use and Overdose in BC: Making the case for greater availability of Take Home Naloxone programs Ashraf Amlani Harm Reduction Epidemiologist.
Prescription Drug Misuse and Abuse Rising Concerns Nationally and Locally.
Jennifer R. Havens, PhD, MPH Associate Professor
SARAH M. BAGLEY, MD ASSISTANT PROFESSOR OF MEDICINE AND PEDIATRICS BOSTON UNIVERSITY SCHOOL OF MEDICINE AMERSA ANNUAL CONFERENCE NOVEMBER 5, 2015 Overdose.
1 Prescribing Pain Medication – Guidelines for the Emergency Department April 22, 2012 Jennifer Sabel, PhD.
Summary Report and Recommendations on Prescription Drugs: Misuse, Abuse and Dependency Presentation for the County Alcohol and Drug Program Administrators’
Risk Management of Modified- Release Opiate Analgesics: Palladone Sharon Hertz, M.D. Medical Team Leader, Analgesics Division of Anesthetic, Critical Care,
Safe Prescribing of Opioids for the Management of Chronic Nonterminal Pain La Tanya Austin, PGY3.
Substance Use Disorders and Overdose: The Basics Public Curricula – Essential Knowledge for Families and Communities Core Component.
The Prescription Opioid & Heroin Crisis: Addiction & Medication Assisted Treatment Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation.
Prescription Drug Monitoring Presented by: Len Abbott, Ph.D. Director Science and Technology Kathleen Valentine, General Manager PDM & Toxicology May 14,
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
The AMA: Reducing Opioid Abuse in America Patrice A. Harris, MD, MA Board Chair American Medical Association September 2016.
Deadly trio: mental health – HIV - drugs
Generalized Logit Model
OPIOID EPIDEMIC.
*Risk Evaluation and Mitigation Strategy
Center of Excellence for Suicide Prevention
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
Opioids Aware A resource for patients and healthcare professionals to support prescribing of opioid medicines for pain.
10th Annual Susan Li Conference
Understanding Associations Between Serious Mental Illness and Hepatitis C among Veterans: A National Multivariate Analysis Seth Himelhoch, MD, MPH,1,2.
Preliminary reliability and validity of an opioid overdose risk behavior scale in a community-based sample of recent veterans E.R. Pouget, A.S. Bennett,
Understanding the Opioid Epidemic
Opioid Crisis A Call to ACTION
ROOM project Addressing the Opioid Epidemic in the U.P.
Opioid Prescribing & Monitoring
The Myths and Realities of the Opioid Epidemic AMERSA November 3, 2017
Department of Health Management and Informatics
Differentiating Drug-Seeking Behavior From Poorly Controlled Pain
Addiction Why It’s YOUR Business
Using Data for Change Barry T. Schmidt, MPH, CPC-R
Supported in part by Arkansas Blue Cross and Blue Shield
buprenorphine-naloxone
Substance Use Prevention for Young Adults and Higher Education
Tapering and Discontinuing Chronic Opioid Therapy
Can be personalized to individual group needs.
Presentation transcript:

Prescription Opioids: Extramedical Use and Overdose Amy S.B. Bohnert, Ph.D. VA National Serious Mental Illness Treatment Resource & Evaluation Center VA Ann Arbor HSR&D Center of Excellence, Center for Clinical Management Research University of Michigan Medical School, Department of Psychiatry

No conflicts of interest to report. Acknowledgements Supported by funding from Veteran Health Administration, Office of Mental Health Services and VA HSR&D grant CDA-09-204, and the University of Michigan Department of Psychiatry and Injury Center. No conflicts of interest to report. Collaborators: Matt Bair Frederic Blow Anna Eisenberg Dara Ganoczy Rose Ignacio Mark Ilgen John McCarthy Amanda Price Marcia Valenstein

Prescription Opioids: Research Goals What are groups that have a high prevalence of use? Where can they be found? How can we better measure prescription opioid use that is not part of medical care? How can we reduce the harms associated with prescription opioids (OVERDOSE)?

Use of Prescription Opioids in the U.S. Prescription Opioids: pain medications that contain opioids (naturally occurring or synthetic) and require a prescription in the U.S., including codeine, percocet, fentanyl etc. Pain Treatment Extramedical Use Non-Medical Use

Non-Medical Prescription Opioid Use in the U.S. Source: SAMSHA

Research Goals 1 + 2 What are groups that have a high prevalence of use? Where can they be found? How can we better measure prescription opioid use that is not part of medical care?

Study 1: Extramedical use among patients at a residential addictions treatment program Residential Treatment Unit- addictions treatment in which patients live together at the treatment center Use is likely to be common- allows us to consider measurement issues Cross-sectional survey, n = 351 Participants largely in treatment for alcohol or cocaine use-related problems

Opioid Use Measurement (past 30 days) 1 item from the Addiction Severity Index (ASI) Days used non-prescribed opiates/analgesics 6 items from the Current Opiate Misuse Measure (COMM) Scale: Never – Rarely – Sometimes – Often – Very Often Taking medication belonging to someone else Going to someone other than the prescribing physician Taking more than prescribed Taking differently than prescribed Using for symptoms other than pain (e.g., improve mood, help sleep, relieve stress) Borrowed pain medications

Study 1 Results: Past 30 Day Extramedical Use COMM: 68% (n = 238) endorsed at least one of six items ASI: 25% (n = 89) reported at least one day of use

Price, Ilgen, & Bohnert, 2011 JSAT

Motives for Opioid Pain Medication Use

Study 2: Extramedical use among emergency department (ED) patients EDs have an elevated prevalence of drug use, are a location of brief intervention trials ED-based study of prescription opioid use Survey of 1,027 patients age 18-60 presenting at an urban ED 33% in ED for an injury 4 modified COMM items to assess use

Study 2: Results Past 3 month opioid pain medication use (including medical use): 49.5% (n = 508) Among those with any use, 50.6% (n = 257) reported extra-medical use (~25% sample) Source non-medical: 47.1% More than prescribed: 61.1% For reasons other than pain relief: 35.0% Some else’s Rx: 40.9% Of those with extramedical use, 20.2% had a prior non-fatal overdose

Research Goal 3 How can we reduce the harms associated with prescription opioids? Dramatic increase in unintentional opioid overdoses

Fatal Accidental Overdoses are Increasing in the US Bohnert, Fudalej, & Ilgen, 2010, Pub Health Rep

Opioid Analgesics: Sales and Overdoses Source: Medscape/CDC

Causes of Prescription Opioid Overdose in the U.S. Extra-Medical Use Pain Treatment Strategies: -Prescription monitoring systems -Prescribing practices -Patient and caregiver education Strategies: -Diversion reduction -Universal prevention to reduce initiation -Harm and use reduction -Naloxone?

Study 3: Prescription opioid overdoses among VHA patients Case-cohort study, 2004-2008 1,136 prescription opioid overdose decedents (of 5,719,542 patients) 750 (66%) had been prescribed opioids Random Sample = 154,684 Data Sources: National Death Index, VHA Patient Records Focus on prescribing regimen (dose + schedule)

From Bohnert, Bair, Valenstein et al., 2011 JAMA

From Bohnert, Bair, Valenstein et al., 2011 JAMA

Conclusions Non-medical/Extra-medical prescription opioid use is common among some specific sub-populations of adults Prescription opioid overdose is a pressing public health concern A number of different types of interventions that target medical use and non-medical use of prescription opioids are needed

Future Directions What about other high-risk sub-groups? Psychiatric patients Developing prescription opioid overdose prevention strategies Extramedical Use Injury Center Pilot Medical Use project on VA opioid prescribing

Thank you! Questions? Amy S.B. Bohnert amybohne@med.umich.edu